COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,725 Articles (22,913 medRxiv, 8,812 bioRxiv)

Most recent first Previous |  Page 2429: Articles 24281-24290  | Next

How to handle the deceased body of COVID-19: an insight from Indonesian muslim burial handlers knowledge, perception, and practice
Purnama, T. B., Khadijah, S., Sadri, I.
10.1101/2020.08.03.20167593 — Posted: 2020-08-07 Discussion: Offsite
Clinical and intestinal histopathological findings in SARS-CoV-2/COVID-19 patients with hematochezia
Cho, M., Liu, W., Balzora, S., Suarez, Y., Hoskoppal, D., Theise, N. D., Cao, W., Sarkar, S. A.
10.1101/2020.07.29.20164558 — Posted: 2020-08-07
Characterization of Israeli COVID-19 Outbreak Drivers and Forecasting Using a Versatile Web App
Getz, W. M., Salter, R., Horvitz, N., Luisa Vissat, L.
10.1101/2020.08.06.20155804 — Posted: 2020-08-07
Prediction of Covid-19 Infections Through December 2020 for 10 US States Using a Two Parameter Transmission Model Incorporating Outdoor Temperature and School Re-Opening Effects
Newell, T. A.
10.1101/2020.08.06.20169896 — Posted: 2020-08-07
The association between lockdown due to COVID-19 epidemic and searches for toothache using Google Trends in Iran
Sofi-Mahmudi, A., Shamsoddin, E., Ghasemi, P., Mehrabi Bahar, A., Shaban Azad, M., Sadeghi, G.
10.1101/2020.08.06.20160515 — Posted: 2020-08-07
Kinetics of viral clearance and antibody production across age groups in SARS-CoV-2 infected children
Bahar, B., Jacquot, C., Mo, Y. D., DeBiasi, R., Delaney, M.
10.1101/2020.08.06.20162446 — Posted: 2020-08-07 Discussion: Onsite
The Epidemiology Characteristics of Positive COVID-19 patients in a Caribbean Territory.
Gopaul, C. D., Ventour, D., Trotman, M., Thomas, D.
10.1101/2020.08.06.20148288 — Posted: 2020-08-07
A Long-Lasting Sanitizing Skin Protectant based on CAGE, a Choline and Geranic Acid Eutectic
Shevachman, M., Mandal, A., Mitragotri, S., Joshi, N.
10.1101/2020.08.04.20161067 — Posted: 2020-08-07
Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate
Bangaru, S., Ozorowski, G., Turner, H. L., Antanasijevic, A., Huang, D., Wang, X., Torres, J. L., Diedrich, J. K., Tian, J.-H., Portnoff, A. D., Patel, N., Massare, M. J., Yates, J. R., Nemazee, D., Paulson, J. C., Glenn, G., Smith, G., Ward, A. B.
10.1101/2020.08.06.234674 — Posted: 2020-08-06
Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors
Osipiuk, J., Azizi, S.-A., Dvorkin, S., Endres, M., Jedrzejczak, R., Jones, K. A., Kathayat, R. S., Lisnyak, V. G., Maki, S. L., Kang, S., Kim, Y., Nicolaescu, V., Taylor, C. A., Tesar, C., Zhang, Y.-A., Zhou, Z., Randall, G., Michalska, K., Snyder, S. A., Dickinson, B. C., Joachimiak, A.
10.1101/2020.08.06.240192 — Posted: 2020-08-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).